124 related articles for article (PubMed ID: 2446551)
1. Acetylcholine receptor-specific human T-lymphocyte lines.
Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
[No Abstract] [Full Text] [Related]
2. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
[No Abstract] [Full Text] [Related]
3. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
[TBL] [Abstract][Full Text] [Related]
5. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit.
Hohlfeld R; Toyka KV; Miner LL; Conti-Tronconi BM
Ann N Y Acad Sci; 1988; 540():511-2. PubMed ID: 2462826
[No Abstract] [Full Text] [Related]
7. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
[TBL] [Abstract][Full Text] [Related]
8. Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptor.
Tami JA; Krolick KA
Ann N Y Acad Sci; 1988; 540():340-2. PubMed ID: 2462808
[No Abstract] [Full Text] [Related]
9. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
[TBL] [Abstract][Full Text] [Related]
10. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
Protti MP; Manfredi AA; Straub C; Wu XD; Howard JF; Conti-Tronconi BM
J Immunol; 1990 Mar; 144(5):1711-20. PubMed ID: 1968487
[TBL] [Abstract][Full Text] [Related]
11. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
[TBL] [Abstract][Full Text] [Related]
12. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
Christadoss P; Shenoy M; Oshima M; Atassi MZ
Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
[No Abstract] [Full Text] [Related]
13. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
[No Abstract] [Full Text] [Related]
14. An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.
Nicolle MW; Vincent A; Sharma S; Nag B; Willcox N; Newsom-Davis J
Ann N Y Acad Sci; 1993 Jun; 681():577-80. PubMed ID: 8357203
[No Abstract] [Full Text] [Related]
15. Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis.
Hohlfeld R; Toyka KV; Miner LL; Walgrave SL; Conti-Tronconi BM
J Clin Invest; 1988 Mar; 81(3):657-60. PubMed ID: 2449458
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
[TBL] [Abstract][Full Text] [Related]
17. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
Rosenberg JS; Oshima M; Atassi MZ
J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
[TBL] [Abstract][Full Text] [Related]
18. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients.
Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T
Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325
[TBL] [Abstract][Full Text] [Related]
19. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
20. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
